Chemical Structure : CHD1Li 6.11
CAS No.: 2716890-91-2
货号: PC-72745Not For Human Use, Lab Use Only.
CHD1Li 6.11 (OTI-611) is a first in class, orally bioavailable oncogenic CHD1L inhibitor with 3.3 uM (CHD1L-cat enzyme activity).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1780 | In stock | |
10 mg | ¥2780 | In stock | |
25 mg | ¥4780 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CHD1Li 6.11 (OTI-611) is a first in class, orally bioavailable oncogenic CHD1L inhibitor with 3.3 uM (CHD1L-cat enzyme activity).
CHD1Li 6.11 exhibits cytotoxicity with IC50 of 2.59 uM in SW620 parental tumor organoid.
CHD1Li 6.11 significantly reduced the tumor volume of CRC xenografts generated from isolated quasi mesenchymal cells (M-phenotype).
Chromodomain helicase DNA-binding protein 1 like (CHD1L) is an oncogene implicated in tumor progression, multidrug resistance, and metastasis in many types of cancer.
分子量 | 472.405 | |
分子式 | C21H22BrN5OS | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-(4-bromothiophen-2-yl)-N-(4-((6-methyl-2-(pyrrolidin-1-yl)pyrimidin-4-yl)amino)phenyl)acetamide |
1. Brett J Prigaro, et al. J Med Chem. 2022 Mar 10;65(5):3943-3961.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright